Peter Gilgan Centre for Women's Cancers (Lofters), Women's College Hospital; Department of Family and Community Medicine (Lofters), University of Toronto; Cancer Rehabilitation and Survivorship (Bender), Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network; ICES (Lofters, Swayze); Dalla Lana School of Public Health (Bender), University of Toronto; Department of Medicine and Institute of Health Policy, Management, and Evaluation (Alibhai), University of Toronto; Department of Medicine (Alibhai), University Health Network; Institute of Health Policy, Management and Evaluation (Bender), University of Toronto; ; Walnut Foundation (Henry, Noel), Toronto, Ont.; Department of Medicine (Datta), Cedar-Sinai Medical Center; Cancer Research Center for Health Equity (Datta), Samuel Oschin Comprehensive Cancer Institute, Los Angeles, Calif.
CMAJ Open. 2022 Nov 1;10(4):E956-E963. doi: 10.9778/cmajo.20220069. Print 2022 Oct-Dec.
Prostate cancer incidence has been associated with various sociodemographic factors, such as race, income and age, but the association with immigrant status in Canada is unclear. In this population-based study in Ontario, Canada, we compared age-standardized incidence rates for immigrant males from various regions of origin with the rates of long-term residents.
In this retrospective cohort study, we linked several provincial-level databases available at ICES, an independent, non-profit research institute. We included all males aged 20 years and older in the province of Ontario eligible for health care for each fiscal year (Apr. 1 to Mar. 31) in 2008-2016. We determined age-standardized prostate cancer incidence rates, stratifying by immigrant status (a binary variable) and region of origin. We used a log-binomial model to estimate adjusted incidence rate ratios, with long-term residents (Canadian-born Ontarians as well as those who immigrated before 1985, when available data on immigration starts) as the reference group. We included age, neighbourhood income and time since landing in the models. Additional models limited to immigrant males in the cohort included immigration admission category (economic class, family class, refugee, other) and time since landing in Canada.
There were 74594 incident cases of prostate cancer in the study period, 6742 of which were among immigrant males. Males who had immigrated from West Africa and the Caribbean had significantly higher incidence of prostate cancer than other immigrants and long-term residents: adjusted rate ratios of 2.71 (95% confidence interval [CI] 2.41-3.05) and 1.91 (95% CI 1.78-2.04), respectively. Immigrants from other regions, including East Africa and Middle-Southern Africa, had lower or similar incidence rates to long-term residents. Males from South Asia had the lowest adjusted rate ratio (0.47, 95% CI 0.45-0.50).
The age-standardized incidence rate of prostate cancer from 2008 to 2016 was consistently and significantly higher among immigrants from West African and Caribbean countries than among other immigrants and long-term residents of the province. Future research in Canada should focus on further understanding heterogeneity in prostate cancer risk and epidemiology, including stage of diagnosis and mortality, for immigrants.
前列腺癌的发病率与多种社会人口因素有关,如种族、收入和年龄,但在加拿大与移民身份的关联尚不清楚。在这项安大略省的基于人群的研究中,我们比较了来自不同原籍地区的移民男性与长期居民的标准化发病率。
在这项回顾性队列研究中,我们在独立的非营利性研究机构 ICES 中链接了几个省级数据库。我们纳入了安大略省所有在 2008 年至 2016 年每个财政年度(4 月 1 日至 3 月 31 日)有资格获得医疗保健的 20 岁及以上男性。我们根据移民身份(二分变量)和原籍地区确定了标准化的前列腺癌发病率。我们使用对数二项式模型估计调整后的发病率比值,以长期居民(加拿大出生的安大略居民以及那些在 1985 年之前移民的人,当时可用的移民开始数据)为参照组。我们将年龄、社区收入和登陆后时间纳入模型。限于队列中移民男性的其他模型包括移民入境类别(经济类、家庭类、难民类、其他类)和登陆后在加拿大的时间。
在研究期间,有 74594 例前列腺癌病例,其中 6742 例为移民男性。从西非和加勒比地区移民的男性前列腺癌发病率明显高于其他移民和长期居民:调整后的发病率比值分别为 2.71(95%置信区间 [CI] 2.41-3.05)和 1.91(95% CI 1.78-2.04)。来自其他地区(包括东非和中南非)的移民的发病率较低或与长期居民相似。南亚男性的调整后发病率比值最低(0.47,95% CI 0.45-0.50)。
2008 年至 2016 年,来自西非和加勒比国家的移民的前列腺癌标准化发病率始终明显高于其他移民和该省的长期居民。加拿大的未来研究应重点进一步了解移民的前列腺癌风险和流行病学的异质性,包括诊断阶段和死亡率。